These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18382609)

  • 1. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
    Loria V; Dato I; Graziani F; Biasucci LM
    Mediators Inflamm; 2008; 2008():135625. PubMed ID: 18382609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myeloperoxidase as possible diagnostic and prognostic marker of acute coronary syndrome].
    Gustapane M; Cardillo MT; Biasillo G; Biasucci LM
    Recenti Prog Med; 2011 Nov; 102(11):447-50. PubMed ID: 22120783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?
    Sinning C; Schnabel R; Peacock WF; Blankenberg S
    Congest Heart Fail; 2008; 14(4 Suppl 1):46-8. PubMed ID: 18772634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase and Neurological Disorder: A Crosstalk.
    Pravalika K; Sarmah D; Kaur H; Wanve M; Saraf J; Kalia K; Borah A; Yavagal DR; Dave KR; Bhattacharya P
    ACS Chem Neurosci; 2018 Mar; 9(3):421-430. PubMed ID: 29351721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis.
    Kolodziej AR; Abo-Aly M; Elsawalhy E; Campbell C; Ziada KM; Abdel-Latif A
    Mediators Inflamm; 2019; 2019():2872607. PubMed ID: 31341419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
    Calmarza P; Lapresta C; Martínez M; Lahoz R; Povar J
    Arch Cardiol Mex; 2018 Dec; 88(5):391-396. PubMed ID: 29233491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical implications of relationship between myeloperoxidase and acute coronary syndromes].
    Li SH; Xing YW; Li ZZ; Bai SG; Wang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):241-4. PubMed ID: 17582289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.
    Singh U; Devaraj S; Jialal I
    Clin Chem; 2009 Feb; 55(2):361-4. PubMed ID: 19074520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome.
    Blanchet X; Cesarek K; Brandt J; Herwald H; Teupser D; Küchenhoff H; Karshovska E; Mause SF; Siess W; Wasmuth H; Soehnlein O; Koenen RR; Weber C; von Hundelshausen P
    Thromb Haemost; 2014 Dec; 112(6):1277-87. PubMed ID: 25183015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic value of myeloperoxidase on acute coronary syndrome: a meta-analysis.
    Chen Y; Zhang F; Dong L; Shu X
    Arch Med Res; 2011 Jul; 42(5):368-74. PubMed ID: 21803086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase and coronary arterial disease: from research to clinical practice.
    Roman RM; Wendland AE; Polanczyk CA
    Arq Bras Cardiol; 2008 Jul; 91(1):e11-9. PubMed ID: 18660935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of acute coronary syndromes: focus on novel biomarkers.
    Tousoulis D; Hatzis G; Papageorgiou N; Androulakis E; Bouras G; Giolis A; Bakogiannis C; Siasos G; Latsios G; Antoniades C; Stefanadis C
    Curr Med Chem; 2012; 19(16):2572-87. PubMed ID: 22489714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
    Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
    Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
    Liang J; Zheng Z; Wang M; Han L; Zheng Z; Peng J; Liu Z; Wei Y
    J Int Med Res; 2009; 37(3):862-6. PubMed ID: 19589271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
    Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D
    Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.
    Ndrepepa G
    Clin Chim Acta; 2019 Jun; 493():36-51. PubMed ID: 30797769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
    Morrow DA; Sabatine MS; Brennan ML; de Lemos JA; Murphy SA; Ruff CT; Rifai N; Cannon CP; Hazen SL
    Eur Heart J; 2008 May; 29(9):1096-102. PubMed ID: 18339606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vocational integration of the worker suffering from ischemic heart disease: prognostic factors, occupational evaluation, and criteria for the assessment of their suitability for the specific task].
    Taino G; Brevi M; Gazzoldi T; Imbriani M
    G Ital Med Lav Ergon; 2013; 35(2):102-19. PubMed ID: 23914603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.
    Liu C; Xie G; Huang W; Yang Y; Li P; Tu Z
    J Atheroscler Thromb; 2012; 19(5):435-43. PubMed ID: 22659527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.